DE2639012C3 - Inununtherapeutikum zur Prophylaxe und Therapie von Pseudomonas aeruginosa-Infektionen - Google Patents

Inununtherapeutikum zur Prophylaxe und Therapie von Pseudomonas aeruginosa-Infektionen

Info

Publication number
DE2639012C3
DE2639012C3 DE2639012A DE2639012A DE2639012C3 DE 2639012 C3 DE2639012 C3 DE 2639012C3 DE 2639012 A DE2639012 A DE 2639012A DE 2639012 A DE2639012 A DE 2639012A DE 2639012 C3 DE2639012 C3 DE 2639012C3
Authority
DE
Germany
Prior art keywords
antibodies
pseudomonas aeruginosa
protease
oep
elastase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2639012A
Other languages
German (de)
English (en)
Other versions
DE2639012B2 (de
DE2639012A1 (de
Inventor
Yuzuru Tokio Homma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Publication of DE2639012A1 publication Critical patent/DE2639012A1/de
Publication of DE2639012B2 publication Critical patent/DE2639012B2/de
Application granted granted Critical
Publication of DE2639012C3 publication Critical patent/DE2639012C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2639012A 1976-02-05 1976-08-30 Inununtherapeutikum zur Prophylaxe und Therapie von Pseudomonas aeruginosa-Infektionen Expired DE2639012C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1086676A JPS5296731A (en) 1976-02-05 1976-02-05 Prophylactics and remedies of cyanomycosis

Publications (3)

Publication Number Publication Date
DE2639012A1 DE2639012A1 (de) 1977-08-11
DE2639012B2 DE2639012B2 (de) 1978-08-03
DE2639012C3 true DE2639012C3 (de) 1979-06-28

Family

ID=11762262

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2639012A Expired DE2639012C3 (de) 1976-02-05 1976-08-30 Inununtherapeutikum zur Prophylaxe und Therapie von Pseudomonas aeruginosa-Infektionen

Country Status (7)

Country Link
US (1) US4120950A (cg-RX-API-DMAC7.html)
JP (1) JPS5296731A (cg-RX-API-DMAC7.html)
AT (1) AT343798B (cg-RX-API-DMAC7.html)
DE (1) DE2639012C3 (cg-RX-API-DMAC7.html)
DK (1) DK143249C (cg-RX-API-DMAC7.html)
FR (1) FR2361905A1 (cg-RX-API-DMAC7.html)
GB (1) GB1545862A (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
CA1247527A (en) * 1983-06-14 1988-12-28 Michael S. Collins High titer pseudomonas immune serum globulin
JPS6112629A (ja) * 1984-06-28 1986-01-21 Lion Corp 口腔内組成物
DE3508384A1 (de) * 1985-03-08 1986-11-06 Boehringer Mannheim Gmbh, 6800 Mannheim Hemmung humaner speichel- und pankreasamylase durch monoklonale antikoerper
GB8519848D0 (en) * 1985-08-07 1985-09-11 Schweiz Rotes Kreuz Treatment of chronic inflammatory disease
US4772465A (en) * 1986-10-27 1988-09-20 Miles Laboratories, Inc. Method of treating polymicrobial burn wound sepsis with a combination therapy of ciprofloxacin and pseudomonas immune globulin
RU2348425C2 (ru) * 2005-06-07 2009-03-10 ГНУ Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Способ изготовления ассоциированной вакцины против стрептококкоза и псевдомоноза песцов и лисиц
RU2309767C1 (ru) * 2006-03-20 2007-11-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Способ изготовления вакцины против псевдомоноза свиней
RU2308288C1 (ru) * 2006-03-20 2007-10-20 Федеральное государственное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Вакцина поливалентная против псевдомоноза сельскохозяйственных животных
CN108138213A (zh) * 2015-02-20 2018-06-08 罗尔公司 控制蛋白酶产生的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947575A (en) * 1969-06-30 1976-03-30 E. R. Squibb & Sons, Inc. Peptides as argiotensin converting enzyme inhibitors
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum

Also Published As

Publication number Publication date
JPS5296731A (en) 1977-08-13
DK143249C (da) 1981-11-30
FR2361905A1 (fr) 1978-03-17
FR2361905B1 (cg-RX-API-DMAC7.html) 1981-11-20
DK143249B (da) 1981-08-03
ATA637776A (de) 1977-10-15
DE2639012B2 (de) 1978-08-03
US4120950A (en) 1978-10-17
GB1545862A (en) 1979-05-16
DK42677A (da) 1977-08-06
DE2639012A1 (de) 1977-08-11
AT343798B (de) 1978-06-12
JPS546608B2 (cg-RX-API-DMAC7.html) 1979-03-30

Similar Documents

Publication Publication Date Title
DE2936047C2 (cg-RX-API-DMAC7.html)
DE3784720T2 (de) Produkt, praeparat und methode zum bekaempfen der allergien.
DE2606118C2 (de) Verfahren zur Herstellung eines gereinigten Gamaglobulins und intravenös verabreichbares Arzneimittel
DE2804457C2 (de) Immunsuppressive Mittel
DE2751717A1 (de) Neue verbesserte gammaglobuline fuer intravenoese injektion und verfahren zu ihrer herstellung
CH655010A5 (de) Pharmazeutischer wirkstoff mit antitumoraktivitaet.
DE2639012C3 (de) Inununtherapeutikum zur Prophylaxe und Therapie von Pseudomonas aeruginosa-Infektionen
DE2827027C3 (de) Gefriergetrocknetes natives Γ-globulin-Präparat zur intravenösen Verabreichung
DE3701066A1 (de) Intravenoes injizierbares immunglobulin mit hohem antikoerpertiter gegenueber dem respiratorischen syncytialvirus, verfahren zu dessen herstellung und pharmazeutische zubereitung, welche dieses enthaelt
DE3850433T2 (de) Allergiebehandlung und Zusammensetzung dafür.
DE2127159A1 (de) Verfahren zur Fraktionierung von Plasmaproteinen
DE69128781T2 (de) Zusammensetzung und methode zur immunstimulierung in säugetieren
DE3636826A1 (de) Varicella-zoster-immunglobulin mit hohem titer fuer eine intravenoese verabreichung
EP0201004A2 (de) Polyvalentes Hyperimmunglobulin-Präparat
DE1940130C2 (de) Verfahren zur Reinigung von Insulin, nach diesem Verfahren gereinigtes Insulin und dessen Verwendung
DE2533183C3 (de) Verfahren zum Herstellen gereinigter Immunglobuline
DE1792555B2 (de) Verfahren zur Herstellung einer für die intravenöse Anwendung geeigneten Gammaglobulinlösung
DE60118409T2 (de) Herstellungsverfahren von immunglobulinen, die gegen menschliche thymozyten gerichtet sind
DE3032606A1 (de) Polysaccharidderivat der streptokinase, verfahren zu dessen herstellung und anwendung
DE2311333C2 (de) Verfahren zur Herstellung eines intravenös injizierbaren modifizierten Immunserumglobulins
AT226372B (de) Dessaggregiertes Gammaglobulin und Verfahren zu seiner Herstellung
DE2425678A1 (de) Verfahren zur herstellung eines impfstoffs gegen infektioese pferdeanaemie
DE1667908B1 (de) Polyvalenter Impfstoff gegen Pseudomonas aeruginosa Infektionen
DE1667908C (de) Polyvalenter Impfstoff gegen Pseudo monas aeruginosa Infektionen
DE1617288C (de) Verfahren zur Herstellung eines Grippe virusimpfstoffs

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee